3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
9
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Lymphoma
2
Wilms Tumor
1
Skin Neoplasms
1
Sezary Syndrome
1
Opioid-Related Disorders
1
Mycosis Fungoides
1
Motor Activity
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Hodgkin Disease
1
Hepatic Veno-Occlusive Disease
1
Breast Neoplasms
1
Interventions
Cyclophosphamide
10
pembrolizumab
9
Therapeutics
8
Flow Cytometry
6
Radiotherapy
5
Gemcitabine
5
Blood Specimen Collection
5
Surveys and Questionnaires
4
Sirolimus
4
Psychiatric Rehabilitation
4
Peripheral Blood Stem Cell Transplantation
4
Paclitaxel
4
Nivolumab
4
Methods
4
Ipilimumab
4
Filgrastim
4
Exercise
4
Drug Therapy
4
Doxorubicin
4
Capecitabine
4
copanlisib
3
aldesleukin
3
Rituximab
3
Polymerase Chain Reaction
3
Immunologic Techniques
3
Immunoglobulin G
3
Immunoenzyme Techniques
3
Fluorodeoxyglucose F18
3
Early Intervention, Educational
3
Disulfides
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Breast Neoplasms
×
Hematologic Tests
×
Lymphoid
×
Clear all
NCT04541212
2025-06-15
CarChem
Montreal Heart Institute
Active not recruiting
169 enrolled